<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05710000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P05981</UniProt_ID>
  <Seq_Length>417</Seq_Length>
  <Molecule_Weight>45011</Molecule_Weight>
  <KEGG_ID>hsa:3249</KEGG_ID>
  <Orthology_ID>K08665</Orthology_ID>
  <Function_Summary>Plays an essential role in cell growth and maintenance of cell morphology.</Function_Summary>
  <Catalytic_Mechanism>Cleavage after basic amino-acid residues, with Arg strongly preferred to Lys.</Catalytic_Mechanism>
  <Pfam_ID>PF09272:Hepsin-SRCR@@PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Serine protease hepsin non-catalytic chain</Alias>
      <Alias>Transmembrane protease serine 1</Alias>
      <Alias>Serine protease hepsin catalytic chain</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with acetylated low-density lipoproteins, advanced glycation end products, or other polyanionic ligands to initiate a change in cell activity.</Detail>
      <Keyword>Scavenger receptor activity</Keyword>
      <Ontology_ID>GO:0005044</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type exopeptidase activity</Keyword>
      <Ontology_ID>GO:0070008</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the calcium concentration-regulatable energy-independent passage of potassium ions across a lipid bilayer down a concentration gradient.</Detail>
      <Keyword>Calcium-activated potassium channel activity</Keyword>
      <Ontology_ID>GO:0015269</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.</Detail>
      <Keyword>Positive regulation of plasminogen activation</Keyword>
      <Ontology_ID>GO:0010756</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.</Detail>
      <Keyword>Positive regulation of gene expression</Keyword>
      <Ontology_ID>GO:0010628</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the cochlea is generated and organized.</Detail>
      <Keyword>Cochlea morphogenesis</Keyword>
      <Ontology_ID>GO:0090103</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Negative regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The controlled breakdown of the basement membrane in the context of a normal process such as imaginal disc eversion.</Detail>
      <Keyword>Basement membrane disassembly</Keyword>
      <Ontology_ID>GO:0034769</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the surface configuration of a cell.</Detail>
      <Keyword>Regulation of cell shape</Keyword>
      <Ontology_ID>GO:0008360</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process is which a host organism activates or increases the frequency, rate or extent of viral transcription, the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Positive regulation by host of viral transcription</Keyword>
      <Ontology_ID>GO:0043923</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of hepatocyte proliferation.</Detail>
      <Keyword>Positive regulation of hepatocyte proliferation</Keyword>
      <Ontology_ID>GO:2000347</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.</Detail>
      <Keyword>Negative regulation of epithelial cell proliferation</Keyword>
      <Ontology_ID>GO:0050680</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.</Detail>
      <Keyword>Negative regulation of epithelial to mesenchymal transition</Keyword>
      <Ontology_ID>GO:0010719</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events involved in the perception of sound vibration. The vibration is received by a cell and converted into a molecular signal.</Detail>
      <Keyword>Detection of mechanical stimulus involved in sensory perception of sound</Keyword>
      <Ontology_ID>GO:0050910</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell growth.</Detail>
      <Keyword>Positive regulation of cell growth</Keyword>
      <Ontology_ID>GO:0030307</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MAQKEGGRTVPCCSRPKVAALTAGTLLLLTAIGAASWAIVAVLLRSDQEPLYPVQVSSADARLMVFDKTEGTWRLLCSSRSNARVAGLSCEEMGFLRALTHSELDVRTAGANGTSGFFCVDEGRLPHTQRLLEVISVCDCPRGRFLAAICQDCGRRKLPVDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTHSEASGMVTQL</Protein_Seq>
    <DNA_Seq>TCGAGCCCGCTTTCCAGGGACCCTACCTGAGGGCCCACAGGTGAGGCAGCCTGGCCTAGCAGGCCCCACGCCACCGCCTCTGCCTCCAGGCCGCCCGCTGCTGCGGGGCCACCATGCTCCTGCCCAGGCCTGGAGACTGACCCGACCCCGGCACTACCTCGAGGCTCCGCCCCCACCTGCTGGACCCCAGGGTCCCACCCTGGCCCAGGAGGTCAGCCAGGGAATCATTAACAAGAGGCAGTGACATGGCGCAGAAGGAGGGTGGCCGGACTGTGCCATGCTGCTCCAGACCCAAGGTGGCAGCTCTCACTGCGGGGACCCTGCTACTTCTGACAGCCATCGGGGCGGCATCCTGGGCCATTGTGGCTGTTCTCCTCAGGAGTGACCAGGAGCCGCTGTACCCAGTGCAGGTCAGCTCTGCGGACGCTCGGCTCATGGTCTTTGACAAGACGGAAGGGACGTGGCGGCTGCTGTGCTCCTCGCGCTCCAACGCCAGGGTAGCCGGACTCAGCTGCGAGGAGATGGGCTTCCTCAGGGCACTGACCCACTCCGAGCTGGACGTGCGAACGGCGGGCGCCAATGGCACGTCGGGCTTCTTCTGTGTGGACGAGGGGAGGCTGCCCCACACCCAGAGGCTGCTGGAGGTCATCTCCGTGTGTGATTGCCCCAGAGGCCGTTTCTTGGCCGCCATCTGCCAAGACTGTGGCCGCAGGAAGCTGCCCGTGGACCGCATCGTGGGAGGCCGGGACACCAGCTTGGGCCGGTGGCCGTGGCAAGTCAGCCTTCGCTATGATGGAGCACACCTCTGTGGGGGATCCCTGCTCTCCGGGGACTGGGTGCTGACAGCCGCCCACTGCTTCCCGGAGCGGAACCGGGTCCTGTCCCGATGGCGAGTGTTTGCCGGTGCCGTGGCCCAGGCCTCTCCCCACGGTCTGCAGCTGGGGGTGCAGGCTGTGGTCTACCACGGGGGCTATCTTCCCTTTCGGGACCCCAACAGCGAGGAGAACAGCAACGATATTGCCCTGGTCCACCTCTCCAGTCCCCTGCCCCTCACAGAATACATCCAGCCTGTGTGCCTCCCAGCTGCCGGCCAGGCCCTGGTGGATGGCAAGATCTGTACCGTGACGGGCTGGGGCAACACGCAGTACTATGGCCAACAGGCCGGGGTACTCCAGGAGGCTCGAGTCCCCATAATCAGCAATGATGTCTGCAATGGCGCTGACTTCTATGGAAACCAGATCAAGCCCAAGATGTTCTGTGCTGGCTACCCCGAGGGTGGCATTGATGCCTGCCAGGGCGACAGCGGTGGTCCCTTTGTGTGTGAGGACAGCATCTCTCGGACGCCACGTTGGCGGCTGTGTGGCATTGTGAGTTGGGGCACTGGCTGTGCCCTGGCCCAGAAGCCAGGCGTCTACACCAAAGTCAGTGACTTCCGGGAGTGGATCTTCCAGGCCATAAAGACTCACTCCGAAGCCAGCGGCATGGTGACCCAGCTCTGACCGGTGGCTTCTCGCTGCGCAGCCTCCAGGGCCCGAGGTGATCCCGGTGGTGGGATCCACGCTGGGCCTAGGATGGGACGTTTTTCTTCTTGGGCCCGGTCCACAGGTCCAAGGACACCCTCCCTCCAGGGTCCTCTCTTCCACAGTGGCGGGCCCACTCAGCCCCGAGACCACCCAACCTCACCCTCCTGACCCCCATGTAAATATTGTTCTGCTGTCTGGGACTCCTGTCTAGGTGCCCCTGATGACGGGATGCTCTTTAAATAATAAAGATGGTTTTGATTAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Neuronal cell body</CellLocal>
      <Ontology_ID>GO:0043025</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0005789</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell-cell junction</CellLocal>
      <Ontology_ID>GO:0005911</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell surface</CellLocal>
      <Ontology_ID>GO:0009986</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HPN</Gene_Name>
    <Gene_Alias>TMPRSS1</Gene_Alias>
    <Gene_ID>3249</Gene_ID>
    <Genbank_ACCN>NM_002151</Genbank_ACCN>
    <Protein_ACCN>NP_002142</Protein_ACCN>
    <HGNC_ID>5155</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3249</Gene_URL>
    <UCSC_ID>uc002nxq.2</UCSC_ID>
    <EMBL_ID>ENSG00000105707</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=HPN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cancer</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cancer?search=HPN#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of the extracellular region of the transmembrane serine protease hepsin with covalently bound preferred substrate.</PDB_Title>
      <PDB_ID>1Z8G</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Z8G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers</PubMed_Title>
      <Author>Herter, S., et al.</Author>
      <Journal>Biochem.J.(2005)390:125-136</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15839837?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Extracellular domain of human hepsin</PDB_Title>
      <PDB_ID>1P57</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P57</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Structure of the Extracellular Region of Human Hepsin Reveals a Serine Protease Domain and a Novel Scavenger Receptor Cysteine-Rich (SRCR) Domain</PubMed_Title>
      <Author>Somoza, J.R., et al.</Author>
      <Journal>Structure(2003)11:1123-1131</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12962630?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)</PDB_Title>
      <PDB_ID>1O5E</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O5E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).</PubMed_Title>
      <Author>Katz, B.A., et al.</Author>
      <Journal>J.Mol.Biol.(2004)344:527-547</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15522303?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)</PDB_Title>
      <PDB_ID>1O5F</PDB_ID>
      <Resolution>1.78</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O5F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).</PubMed_Title>
      <Author>Katz, B.A., et al.</Author>
      <Journal>J.Mol.Biol.(2004)344:527-547</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15522303?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human hepsin protease in complex with the Fab fragment of an inhibitory antibody</PDB_Title>
      <PDB_ID>3T2N</PDB_ID>
      <Resolution>2.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3T2N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Allosteric antibody inhibition of human hepsin protease.</PubMed_Title>
      <Author>Koschubs, T., et al.</Author>
      <Journal>Biochem.J.(2012)442:483-494</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22132769?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ddj.b.c.b.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1o5e</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Antibody-induced</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.21.106</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/106.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>